Article Versions Notes

Tanei T, Seno S, Sota Y, Hatano T, Kitahara Y, Abe K, Masunaga N, Tsukabe M, Yoshinami T, Miyake T, et al. High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer. Cancers. 2024; 16(5):1062. https://doi.org/10.3390/cancers16051062

Tanei, Tomonori, Shigeto Seno, Yoshiaki Sota, Takaaki Hatano, Yuri Kitahara, Kaori Abe, Nanae Masunaga, Masami Tsukabe, Tetsuhiro Yoshinami, Tomohiro Miyake, and et al. 2024. "High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer" Cancers 16, no. 5: 1062. https://doi.org/10.3390/cancers16051062

Tanei, T., Seno, S., Sota, Y., Hatano, T., Kitahara, Y., Abe, K., Masunaga, N., Tsukabe, M., Yoshinami, T., Miyake, T., Shimoda, M., Matsuda, H., & Shimazu, K. (2024). High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer. Cancers, 16(5), 1062. https://doi.org/10.3390/cancers16051062